Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,259 | -2,522 | -4,845 | -3,091 | -1,849 |
| Depreciation Amortization | 329 | 103 | 293 | 209 | 132 |
| Accounts payable and accrued liabilities | 296 | 253 | -23 | 170 | 52 |
| Other Working Capital | 187 | -316 | -108 | 123 | 45 |
| Other Operating Activity | 150 | 0 | 886 | 120 | 152 |
| Operating Cash Flow | $-6,297 | $-2,482 | $-3,797 | $-2,468 | $-1,469 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -178 | -157 | -548 | -491 | -311 |
| Purchase Sale Intangibles | -50 | -50 | N/A | N/A | N/A |
| Other Investing Activity | -50 | -50 | 0 | 0 | 0 |
| Investing Cash Flow | $-228 | $-207 | $-548 | $-491 | $-311 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 827 | 876 | N/A | N/A | N/A |
| Common Stock Issued | 6,361 | 6,361 | 5,970 | 5,938 | 5,938 |
| Financing Cash Flow | $7,188 | $7,237 | $5,970 | $5,938 | $5,938 |
| Beginning Cash Position | 5,091 | 5,091 | 3,466 | 3,467 | 3,467 |
| End Cash Position | 5,754 | 9,639 | 5,091 | 6,445 | 7,625 |
| Net Cash Flow | $663 | $4,548 | $1,625 | $2,979 | $4,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,297 | -2,482 | -3,797 | -2,468 | -1,469 |
| Capital Expenditure | -178 | -157 | -548 | -491 | -311 |
| Free Cash Flow | -6,475 | -2,639 | -4,345 | -2,959 | -1,780 |